|
|
OJHAS: Vol. 2, Issue
4: (2003 Oct-Dec) |
|
|
Delayed Manifestation of Transurethral
Syndrome as a Complication of Transurethral Prostatic Resection |
|
|
Praveen Jadhav, Honorary
Physician
Meera Jadhav, Honorary Surgeon
Pratibha Patel, Honorary Anaesthetist
Sunita Paithankar, Vivek Magdum, Medical Officers
Jairam Hospital and Research Center, Nashik Road, Nashik 422101.
|
|
|
|
|
|
Address For Correspondence |
|
Dr. Praveen Jadhav,
Honorary
Physician
Jairam Hospital and Research Center, Nashik Road, Nashik 422101 E-mail: drpraveenjadhav@rediffmail.com
|
|
|
Jadhav P,
Jadhav M, Patel P, Paithankar S, Magdum V. Delayed Manifestation of Transurethral Syndrome
as a Complication of Transurethral Prostatic Resection.
Online J Health Allied Scs.2003;4:6 |
|
Submitted: Jan 4,
2004; Accepted: Feb 15, 2004; Published: Mar 5, 2004 |
|
|
|
|
|
|
|
|
Abstract: |
Metabolic encephalopathy as a part of
transurethral syndrome is an immediate complication following transurethral
resection of prostate. It occurs during or few hours after the surgery. (1) However,
delayed manifestation of this complication is rare. It is also possible that pretreatment
with diuretics can exaggerate this problem by predisposing the patient to electrolyte
abnormalities. Here we present a report of such a patient who manifested with neurological
complications six days after the prostate surgery.
Key Words:
Metabolic encephalopathy; transurethral syndrome; TURP; diuretics |
|
Seventy four year old male was
operated for prostate enlargement. He was a known case of hypertension and ischemic heart
disease and was on regular treatment with nifedipine, atenolol, indapamide, nitrates,
nicorandil and low dose aspirin. Transurethral prostatic resection was done and bladder
wash was given using 6 liters of glycine. Post-operative course was uneventful and patient
was discharged four days later in a stable condition on pre-existing treatment,
antibiotics (cefixime) and doxazocin.
Two days later patient was brought with
7-8 hours history of increasing drowsiness, uneasiness, chest discomfort, hiccups and
vomiting. He had tachycardia (heart rate of 104 per minute), blood pressure of 150/90
mmHg, and normal chest signs. He was drowsy, had no focal neurological deficit and had
bilateral extensor plantars. His drowsiness increased over the next 4- 5 hours, from being
alert to responding sluggishly to verbal commands. He had a generalized tonic convulsion,
with up rolling of eyeballs and incontinence. His abdomen gradually distended with only
sluggish peristalsis being audible.
His initial investigations revealed serum
sodium of 130 meq/lit, potassium of 2.9 meq/lit, chlorides of 92 meq/lit, calcium of 7.8
mg/dl, magnesium of 1.4 mg/dl, and phosphorus of 2.5 mg/dl. His renal and hepatic
parameters, hemoglobin, clotting profile and CT scan were normal. There was neutrophilic
leucocytosis (WBC count of 12,400 per cubic mm). Electrocardiogram showed generalized T
wave inversion.
He was started on replacement therapy
with potassium drip. Though calcium replacement could have further dropped the potassium
levels, decision was taken to replace the depleted levels of calcium with 10 ml of calcium
gluconate intravenously for the first day. Phenytoin was started for preventing further
convulsions and antibiotics for preventing infections. He was kept nil by mouth with
continuous aspiration of gastric contents.
Repeated electrolyte examinations were
performed. Though potassium levels returned to normal, hyponatremia manifested on the
second day after admission (129 meq/lit). Correspondingly, abdominal distension decreased
and peristalsis reappeared. However, drowsiness persisted with the patient only opening
his eyes voluntarily and not being able to move his limbs. Since intravenous hypertonic
saline was not available, sodium replacement was done orally with 8 hourly Ryle tube feeds
of 4 gm of table salt in 50 ml distilled water. Sodium levels returned to normal in the
next two days to 135 meq/lit. Correspondingly, patients alertness improved and power
in the limbs returned to normal. Oral potassium and table salt supplementation was
continued. Subsequent electrolyte examinations were normal except on the sixth day, when
his potassium dropped to 2.9 meq/lit. That time, he developed atrial fibrillation with
ventricular rate of 140 per minute. Normal sinus rhythm was restored with intravenous
adenosine. For the next 12 days in the hospital, patient had normal electrolyte levels.
Oral supplementation of electrolytes was tapered and omitted. Further stay in the hospital
was complicated by development of deep vein thrombosis, which was appropriately treated.
The patient was discharged asymptomatic on the eighteenth day after admission.
This case highlights two important
points. Though metabolic complications are not uncommon after transurethral prostatic
resection, delayed manifestation of this complication is rare. This report suggests that
it can occur even after six days of the surgery. Manifestation of this complication
depends on the type of the irrigation fluid used, experience of the surgeon (number of
venous channels opened), duration of surgery and peripheral venous pressure. Use of
glycine as irrigating fluid has vastly reduced the incidence of this complication.
However, increased ammonia levels following metabolism of glycine and high levels of
glycine per se can give rise to neurological complications.
More importantly, there is a strong
possibility that pre-operative treatment with diuretic (indapamide) may have contributed
to this complication in this patient. Though, the incidence of hypokalemia with indapamide
treatment is very low, mild hypokalemia and possibly hypomagnesemia is possible with
long-term treatment.(2) Since there is already a propensity for metabolic changes during
prostate surgery, pre-existing electrolyte abnormalities can further complicate the
surgery. Hence, the treating physician and surgeon should make a conscious effort to
elicit history of diuretic treatment prior to prostate surgery. Hypertension being a
common ailment in the age group being operated for prostate enlargement, many of these
patients may be on diuretics. We strongly recommend that these patients should have
estimation of electrolytes as a part of their pre-operative examination.
- Sear JW, Rosewarne F. Anesthesia for
surgeons. In Morris PJ, Malt RA, Editors. Oxford textbook of surgery, volume 1. Oxford
University Press, Oxford, UK, 1994; pp 77-78.
- Poulsen L, Friberg M, Noer I et al.
Comparison of indapamide and hydrochlorthiazide plus amiloride as a third drug in the
treatment of arterial hypertension. Cardiovasc Drugs Ther 1989;3:141-144.
Reviewer's Comments:
It is a well documented fact that
hypertensive patients on diuretics are more prone to developing acute manifestations of
TUR syndrome due to pre-existing subclinical electrolyte abnormalities. The use of 1.5%
Glycine as irrigant solution has reduced the complications related to hypotonicity of
irrigating fluids (sterile water), but complications relating to volume load as well as
biochemical alterations (hyperammonemia) continue to be matter of concern. The occurrence
of clinical and metabolic alterations after a recent TURP has prompted the authors to
presume this to be case of delayed TUR syndrome. Tachycardia and neutrophiic leukocytosis
are pointers towards sepsis, which by itself could cause metabolic encephalopathy and be
responsible for the patient's condition. Recent TURP and diuretic therapy may be only
additional factors complicating the clinical picture. However, as the authors state,
patients on diuretic therapy pre-operatively should be closely monitored in the
perioperative period, clinically and biochemically, to minimize the risk of early or
delayed manifestations of a potentially life-threatening clinical entity. |